Canada markets close in 3 hours 55 minutes

Affimed N.V. (AFMD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.0050-0.0550 (-2.67%)
As of 12:02PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.0600
Open2.0800
Bid2.0100 x 2200
Ask2.0200 x 3200
Day's Range2.0000 - 2.1000
52 Week Range1.9300 - 7.3500
Volume164,338
Avg. Volume1,003,609
Market Cap299.425M
Beta (5Y Monthly)2.30
PE Ratio (TTM)N/A
EPS (TTM)-0.6590
Earnings DateOct 27, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.49
  • Simply Wall St.

    Does Affimed (NASDAQ:AFMD) Have A Healthy Balance Sheet?

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

  • GlobeNewswire

    Affimed To Provide a Clinical Update on AFM24 Monotherapy Dose-escalation at European Society for Medical Oncology (ESMO) Congress 2022

    Selected recommended phase 2 dose (RP2D) of 480 mg with ongoing enrollment in disease-specific cohorts; maximum tolerated dose (MTD) not reachedStable disease was observed in 10 of 27 evaluable patients in an unselected patient populationComprehensive pharmacodynamic studies indicate the activation of the innate as well as the adaptive immune systemWell managed safety profile HEIDELBERG, Germany, Sept. 04, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology com

  • GlobeNewswire

    Affimed to Present at Upcoming Investor Conferences

    HEIDELBERG, Germany, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the Company’s management will participate in the following investor conferences during the month of September 2022. 2022 Wells Fargo Healthcare Conference (September 6-9, 2022)Date: Wednesday, September 7, 2022Presentation Time: 3:10 p.m. Eastern Dayli